Jiangsu Hengrui Pharmaceuticals Co.,Ltd (FRA:0BO)

Market Cap	41.44B -5.6%
Revenue (ttm)	4.09B +11.6%
Net Income	1.02B +18.7%
EPS	0.15 +11.8%
Shares Out	n/a
PE Ratio	40.59
Forward PE	32.54
Dividend	0.02 (0.43%)
Ex-Dividend Date	Apr 29, 2026

Volume	n/a
Open	5.80
Previous Close	6.25
Day's Range	5.80 - 5.85
52-Week Range	5.65 - 10.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About FRA:0BO

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

• Industry: Pharmaceutical Preparations
• Founded: 1970
• Employees: 20,602
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 0BO

Financial Performance

In 2025, FRA:0BO's revenue was 31.63 billion, an increase of 13.02% compared to the previous year's 27.98 billion. Earnings were 7.71 billion, an increase of 21.69%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error